PATENT CLAIM ANALYSIS

Application Number: 15750425
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "139100"]

Abstract:
Anti-CD122 and/or γc antibodies and fragments thereof are disclosed. Also disclosed are compositions comprising such antibodies and fragments, and uses and methods using the same.

Claim (Index 78):
The antibody or antigen binding fragment according to  claim 77 , wherein the antibody or antigen-binding fragment comprises:\n (a) an antigen-binding fragment which binds to CD122, comprising:\n (i) a light chain variable region comprising the following CDRs: \n LC-CDR1: (SEQ ID NO: 2) TGTSSDIGHYDFVS   LC-CDR2: (SEQ ID NO: 3) DINNRPS   LC-CDR3: (SEQ ID NO: 4) SAYTSSDTLV; (ii) a heavy chain variable region comprising the following CDRs: HC-CDR1: (SEQ ID NO: 36) NYYMH   HC-CDR2: (SEQ ID NO: 37) AIMPSRGGTSYPQKFQG   HC-CDR3: (SEQ ID NO: 38) GEYYYDSSGYYY; (b) an antigen-binding fragment which binds to common \u03b3 chain.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 88.0
- Lexical Diversity: 1.4
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15229336', '15495048', '15486468', '15521685', '15521434']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7436126399732621
- 35 USC 102 Novelty (BERT): 0.716988046542631
- Combined Prediction Score: 0.740950180630199
- Mean Citation Score: 532.3024059999998
- Max Citation Score: 948.52997
- Similarity Product: 743.3215989627129

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test